Healthcare -
Biotechnology - NASDAQ - GB
$ 1.6
-4.19 %
$ 6.95 M
Market Cap
-0.61
P/E
VRAX - SHORT-TERM DEBT
Short-term Debt VRAX - Virax Biolabs Group Limited
48 K
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR